For the Inventor, By the Inventor

Enter assignee name

Crystal Pharmaceutical (Suzhou) Co., Ltd.

USPTO Granted Patents = 20

% Expired Patents = 45.0

Forward Citations = 9

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Minhua Chen (19 out of 57 patents)

Yanfeng Zhang (15 out of 59 patents)

Xiaoyu Zhang (12 out of 45 patents)

4. Chunxiang Huang (5 out of 6 patents)

5. Chaohui Yang (3 out of 16 patents)

6. Xiaoting Zhai (3 out of 9 patents)

7. Kai Liu (3 out of 34 patents)

8. Po Zou (3 out of 6 patents)

9. Qiyue Liu (2 out of 3 patents)

10. Jinqiu Wang (2 out of 5 patents)

11. Kaiqiang Yan (2 out of 8 patents)

12. Jiale Qian (2 out of 2 patents)

13. Yuhao Chen (2 out of 2 patents)

14. Jing Zhang (2 out of 12 patents)

15. Yuan Liu (1 out of 4 patents)

20 patents: Sort by Forward Citations

1. 12428402 - Resmetirom crystal, preparation method for same, and uses thereof (2025-09-30),

2. 12162885 - Crystal form of Xevinapant for treating LA SCCHN (2024-12-10),

3. 11827630 - Crystal form of lanifibranor, preparation method therefor, and use thereof (2023-11-28),

4. 11795152 - Crystal form of tafamidis and preparation method therefor and use thereof (2023-10-24),

5. 11572365 - Crystal form of upadacitinib, preparation method therefor, and use thereof (2023-02-07),

6. 11339158 - Crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof (2022-05-24),

7. 11149004 - Crystalline form of EB-1020, processes for preparation and use thereof (2021-10-19),

8. 11136347 - Crystalline forms of a fatty acid bile acid conjugate, preparation method thereof and use thereof (2021-10-05),

9. 11124517 - Crystal form of Baricitinib and preparation method thereof (2021-09-21),

10. 11091494 - Crystal form of acalabrutinib and preparation method and use thereof (2021-08-17),

11. 11066384 - Crystalline forms of ARN-509, preparation method and use thereof (2021-07-20),

12. 10815232 - Crystalline forms of viral-protein inhibitor drug VX-787, processes for preparation thereof and use thereof (2020-10-27),

13. 10815221 - Crystal forms of an androgen receptor antagonist, preparation method and use thereof (2020-10-27),

14. 10759779 - Crystalline form of orexin receptor antagonist, processes for preparation thereof and use thereof (2020-09-01),

15. 10752595 - Crystalline forms of a bromodomain and extraterminal protein inhibitor drug, processes for preparation thereof, and use thereof (2020-08-25),

Crystal Pharmaceutical (Suzhou) Co., Ltd. is a leading pharmaceutical company based in Suzhou, China. We specialize in the research, development, manufacturing, and marketing of high-quality pharmaceutical products. With a strong emphasis on innovation and quality, we strive to provide safe and effective medicines to improve the health and well-being of people worldwide. Our state-of-the-art facilities and experienced team ensure strict adherence to international quality standards at every stage of the production process. Visit our website to learn more about our products, services, and commitment to excellence.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

20 Patents

#23 in Suzhou

#1,452 in China

#31,161 in the World

Crystal Pharmaceutical (Suzhou) Co., Ltd.

Forward Citations = 9

26 inventors:

Minhua Chen (19 out of 57 patents)

Yanfeng Zhang (15 out of 59 patents)

Xiaoyu Zhang (12 out of 45 patents)

4. Chunxiang Huang (5 out of 6 patents)

5. Chaohui Yang (3 out of 16 patents)

Please report any incorrect information to [email protected]

Loading…